4/19
05:29 pm
ocup
Form PRE 14A Ocuphire Pharma, Inc. For: Jun 11
Medium
Report
Form PRE 14A Ocuphire Pharma, Inc. For: Jun 11
4/17
04:24 pm
ocup
Form 8-K Ocuphire Pharma, Inc. For: Apr 11
Medium
Report
Form 8-K Ocuphire Pharma, Inc. For: Apr 11
4/15
04:11 pm
ocup
Form 4 Ocuphire Pharma, Inc. For: Apr 11 Filed by: Pepose Jay
Low
Report
Form 4 Ocuphire Pharma, Inc. For: Apr 11 Filed by: Pepose Jay
3/27
04:28 pm
ocup
Form 8-K Ocuphire Pharma, Inc. For: Mar 27
Low
Report
Form 8-K Ocuphire Pharma, Inc. For: Mar 27
3/25
04:45 pm
ocup
Form 4 Ocuphire Pharma, Inc. For: Mar 21 Filed by: SCHACHLE JOSEPH K
Medium
Report
Form 4 Ocuphire Pharma, Inc. For: Mar 21 Filed by: SCHACHLE JOSEPH K
3/25
04:40 pm
ocup
Form 4 Ocuphire Pharma, Inc. For: Mar 21 Filed by: Jhaveri Nirav S.
Medium
Report
Form 4 Ocuphire Pharma, Inc. For: Mar 21 Filed by: Jhaveri Nirav S.
3/20
04:18 pm
ocup
Form 4 Ocuphire Pharma, Inc. For: Mar 18 Filed by: Magrath George
Medium
Report
Form 4 Ocuphire Pharma, Inc. For: Mar 18 Filed by: Magrath George
3/8
05:21 pm
ocup
Form 10-K Ocuphire Pharma, Inc. For: Dec 31
Medium
Report
Form 10-K Ocuphire Pharma, Inc. For: Dec 31
3/8
08:22 am
ocup
Form 8-K Ocuphire Pharma, Inc. For: Mar 08
High
Report
Form 8-K Ocuphire Pharma, Inc. For: Mar 08
2/16
04:32 pm
ocup
Form 424B3 Ocuphire Pharma, Inc.
Medium
Report
Form 424B3 Ocuphire Pharma, Inc.
2/16
04:03 pm
ocup
Form 8-K Ocuphire Pharma, Inc. For: Feb 12
Low
Report
Form 8-K Ocuphire Pharma, Inc. For: Feb 12
2/14
06:38 pm
ocup
Form 4 Ocuphire Pharma, Inc. For: Feb 12 Filed by: Jhaveri Nirav S.
Low
Report
Form 4 Ocuphire Pharma, Inc. For: Feb 12 Filed by: Jhaveri Nirav S.
2/14
06:35 pm
ocup
Form 4 Ocuphire Pharma, Inc. For: Feb 12 Filed by: Jayagopal Ashwath
Low
Report
Form 4 Ocuphire Pharma, Inc. For: Feb 12 Filed by: Jayagopal Ashwath
2/14
06:33 pm
ocup
Form 3 Ocuphire Pharma, Inc. For: Feb 12 Filed by: Jhaveri Nirav S.
Low
Report
Form 3 Ocuphire Pharma, Inc. For: Feb 12 Filed by: Jhaveri Nirav S.
2/14
06:29 pm
ocup
Form 3 Ocuphire Pharma, Inc. For: Feb 12 Filed by: Jayagopal Ashwath
Low
Report
Form 3 Ocuphire Pharma, Inc. For: Feb 12 Filed by: Jayagopal Ashwath